rs2228510
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1
The NM_003922.4(HERC1):āc.6658A>Gā(p.Ile2220Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.508 in 1,612,970 control chromosomes in the GnomAD database, including 217,062 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_003922.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HERC1 | NM_003922.4 | c.6658A>G | p.Ile2220Val | missense_variant | 37/78 | ENST00000443617.7 | NP_003913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HERC1 | ENST00000443617.7 | c.6658A>G | p.Ile2220Val | missense_variant | 37/78 | 1 | NM_003922.4 | ENSP00000390158.2 | ||
ENSG00000259589 | ENST00000559303.2 | n.225T>C | non_coding_transcript_exon_variant | 3/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.479 AC: 72618AN: 151758Hom.: 18247 Cov.: 30
GnomAD3 exomes AF: 0.444 AC: 110219AN: 248302Hom.: 26880 AF XY: 0.446 AC XY: 60020AN XY: 134718
GnomAD4 exome AF: 0.511 AC: 747182AN: 1461094Hom.: 198800 Cov.: 45 AF XY: 0.507 AC XY: 368434AN XY: 726796
GnomAD4 genome AF: 0.479 AC: 72684AN: 151876Hom.: 18262 Cov.: 30 AF XY: 0.469 AC XY: 34815AN XY: 74222
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 06, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Macrocephaly, dysmorphic facies, and psychomotor retardation Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at